TIDMHIK
RNS Number : 2716X
Hikma Pharmaceuticals Plc
24 April 2023
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 24 April 2023: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards which were granted on 25 February 2021
under the 2014 Executive Incentive Plan ("EIP") Element B and 27
February 2020 under the EIP Element C.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman and Chief Executive Officer
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 34,827
d) Aggregated information
* Volume
34,827
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 27,057
d) Aggregated information
* Volume
27,057
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 24,319
d) Aggregated information
* Volume
24,319
GBP0.00
* Price GBP0.00
Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 18,831
d) Aggregated information
* Volume
18,831
GBP0.00
* Price GBP0.00
Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 20,285
d) Aggregated information
* Volume
20,285
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 22,437
d) Aggregated information
* Volume
22,437
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 11,205
d) Aggregated information
* Volume
11,205
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 10,690
d) Aggregated information
* Volume
10,690
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 17,307
d) Aggregated information
* Volume
17,307
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 17,007
d) Aggregated information
* Volume
17,007
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 17,390
d) Aggregated information
* Volume
17,390
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 17,180
d) Aggregated information
* Volume
17,180
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Brian Hoffmann
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. 4,436
Shares were sold to cover tax and the remainder
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,683
Price(s): GBP18.065
Volume(s): 4,436
d) Aggregated information
* Volume
12,119
GBP18.065
* Price GBP80,136.34
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C. 4,378
Shares were sold to cover tax and the remainder
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,584
Price(s): GBP18.065
Volume(s): 4,378
d) Aggregated information
* Volume
11,962
GBP18.065
* Price GBP79,088.57
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Susan Ringdal
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. 3,990
Shares were sold to cover tax and the remainder
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 4,823
Price(s): GBP18.065
Volume(s): 3,990
d) Aggregated information
* Volume
8,813
GBP18.065
* Price GBP72,079.35
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element C 4,017
Shares were sold to cover tax and the remainder
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 4,857
Price(s): GBP18.065
Volume(s): 4,017
d) Aggregated information
* Volume
8,874
GBP18.065
* Price GBP72,567.105
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 April 2023 under the EIP Element B. All
Shares were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,867
d) Aggregated information
* Volume
7,867
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 April 2023
f) Place of the London Stock Exchange (XLON)
transaction
Hussein Arkhagha
Chief Counsel and Company Secretary
+44 (0) 20 7399 2760
24 April 2023
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBUGDSXBDDGXS
(END) Dow Jones Newswires
April 24, 2023 11:15 ET (15:15 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
